COPANLISIB for B-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 38 adverse event reports in the FDA FAERS database where COPANLISIB was used for B-cell lymphoma.
Most Reported Side Effects for COPANLISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 58 | 16.3% | 10 | 53 |
| Off label use | 43 | 12.1% | 1 | 20 |
| Hyperglycaemia | 27 | 7.6% | 2 | 18 |
| Hypertension | 24 | 6.8% | 1 | 12 |
| Rash maculo-papular | 24 | 6.8% | 4 | 16 |
| Pneumonia | 20 | 5.6% | 6 | 15 |
| Sepsis | 19 | 5.4% | 8 | 12 |
| Diarrhoea | 18 | 5.1% | 2 | 5 |
| Rash | 16 | 4.5% | 3 | 10 |
| Febrile neutropenia | 15 | 4.2% | 6 | 8 |
| Neutropenia | 15 | 4.2% | 3 | 5 |
| Neutropenic sepsis | 15 | 4.2% | 2 | 14 |
| Anaemia | 14 | 3.9% | 4 | 12 |
| Dyspnoea | 14 | 3.9% | 6 | 12 |
| Cytopenia | 13 | 3.7% | 0 | 11 |
Other Indications for COPANLISIB
Follicular lymphoma (42)
Marginal zone lymphoma (29)
Product used for unknown indication (23)
Non-hodgkin's lymphoma recurrent (20)
Diffuse large b-cell lymphoma (17)
Non-hodgkin's lymphoma (11)
B-cell lymphoma recurrent (10)
Diffuse large b-cell lymphoma recurrent (10)
Non-hodgkin's lymphoma unspecified histology indolent (6)
Colorectal cancer (5)
Other Drugs Used for B-cell lymphoma
RITUXIMAB (7,811)
CYCLOPHOSPHAMIDE (4,766)
VINCRISTINE (4,346)
DOXORUBICIN (3,947)
LENALIDOMIDE (3,474)
PREDNISONE (2,561)
BENDAMUSTINE (1,668)
PREDNISOLONE (1,489)
ETOPOSIDE (1,268)
IDELALISIB (1,240)